mesoestetic® launch mesofiller® advanced dermafillers
mesoestetic pharma group has launched mesofiller® to correct wrinkles and restore facial volume.
The new range of dermal implants with cross-linked hyaluronic acid were four years in development and are a monophasic transparent gel of non-animal origin and completely absorbable.
mesofiller has a CE mark compliant with the European directive on medical devices, a guarantee of quality, safety and efficacy.
The products smooth and correct depressions and wrinkles caused by skin ageing. They can also be used to sculpt facial features, create volume and shape and augment the lips.
The mesofiller range is based on densimatrix®technology, a revolutionary cross-linking method associated with an intensive purification process. This unique technology enables the cross-linked of 100% hyaluronic acid chains to ensure better resistance to enzymatic degradation and maximum purity.
There are two highly purified concentrations, ensuring optimal tolerance. mesofiller global and mesofiller intense are ideal to combine with other medical procedures such as chemical peels, botulinum toxin, mesotherapy and pulsed light, for highly personalised treatments.
A clinical study conducted on mesofiller between January 2014 and November 2015 with 30 volunteers shown a considerable improvement in 100% of the cases.
